CM Life Sciences, Inc.

Status: Deal Closed
U=S+W/3 W=S@11.5
Target: Sema4; Closing Date: Jul 22, 2021
IPO Proceeds, $M $442.75M
IPO Date Sep 2, 2020
CEO Eli D. Casdin
Left Lead Jefferies
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences

IPO Geography Global
Target Company Sema4
Deal Announced Feb 10, 2021
Deal Size, $M $2,071.00M
Deal Geography US/Canada
Deal Sector Healthcare
SEC Filings www.sec.gov
Closing Date Jul 22, 2021
Formerly CMLF SMFR SMFRW


Sign up for Free Trial

No credit card required

Sign in for more data on CM Life Sciences, Inc.:

  • 8 directors & officers
  • 19 filings and events
  • 1 underwriters
  • 5 deal advisors
  • 2 legal advisors
  • 237 shareholders (from 13F filings)